Cheng S, Zhang R, Yang F, Li J, et al. Induction therapy with dabrafenib, trametinib, and PD-1 inhibitor and surgical conversion in unresectable stage III non-small cell lung cancers with BRAF V600E mutation: 2 cases. Lung Cancer 2025;205:108592.
PMID: 40466464